Among them, NGAL, KIM-1, and IL-18 were most often studied in patients with AKI and gave the most promising results regarding the early diagnosis and the stratification of AKI risk and outcome [20,21,22,31,32,33,34]. The gene discussed is LCN2; the disease is acute kidney injury.